Berberine: A Plant Alkaloid with Therapeutic Potential for Central Nervous System Disorders

被引:293
|
作者
Kulkarni, S. K. [1 ]
Dhir, Ashish [2 ]
机构
[1] Panjab Univ, Div Pharmacol, Univ Inst Pharmaceut Sci, Chandigarh 160014, India
[2] Univ Calif Davis, Med Ctr, Dept Neurol, Sacramento, CA 95817 USA
关键词
berberine; monoamines; neurological disorders; safety; CONGESTIVE-HEART-FAILURE; COPTIDIS-RHIZOMA EXTRACT; INDUCED DIABETIC-RATS; FORCED SWIM TEST; NITRIC-OXIDE; ANTIDEPRESSANT ACTIVITY; HIPPOCAMPUS; MECHANISM; EFFICACY; CHLORIDE;
D O I
10.1002/ptr.2968
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Berberine, an isoquinoline alkaloid of the protoberberine type found in an array of plants, has been used in Indian and Chinese medicines as an antimicrobial, stomachic, bitter tonic and in the treatment of oriental sores. Although pharmacological investigations of berberine have been reported by many in the past, there is renewed interest in berberine because of its reported beneficial effect in various neurodegenerative and neuropsychiatric disorders. The alkaloid is reported to modulate neurotransmitters and their receptor systems in the brain. This review attempts to discuss the pharmacological basis of the use of berberine in various central nervous system and related disorders. Its protective effect in Alzheimer's, cerebral ischemia, mental depression, schizophrenia and anxiety are highlighted. However, more detailed clinical trials along with a safety assessment of berberine are warranted for positioning the alkaloid in the treatment of neurological disorders. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:317 / 324
页数:8
相关论文
共 50 条
  • [1] Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease
    Zhou, J.
    Chan, L.
    Zhou, S.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (21) : 3523 - 3531
  • [2] Isorhynchophylline: A plant alkaloid with therapeutic potential for cardiovascular and central nervous system diseases
    Zhou, Ji-Yin
    Zhou, Shi-Wen
    FITOTERAPIA, 2012, 83 (04) : 617 - 626
  • [3] The potential therapeutic role of statins in central nervous system autoimmune disorders
    O. Stüve
    S. Youssef
    S. Dunn
    A. J. Slavin
    L. Steinman
    S. S Zamvil
    Cellular and Molecular Life Sciences CMLS, 2003, 60 : 2483 - 2491
  • [4] The potential therapeutic role of statins in central nervous system autoimmune disorders
    Stüve, O
    Youssef, S
    Dunn, S
    Slavin, AJ
    Steinmann, L
    Zamvil, SS
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2003, 60 (11) : 2483 - 2491
  • [5] Therapeutic potential of fucoidan in central nervous system disorders: A systematic review
    Yang, Jing
    Zhao, He
    Qu, Shengtao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 277
  • [6] Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
    Fan, Dahua
    Liu, Liping
    Wu, Zhengzhi
    Cao, Meiqun
    CURRENT NEUROPHARMACOLOGY, 2019, 17 (06) : 563 - 579
  • [7] Proinflammatory cytokines a potential targets for therapeutic intervention in central nervous system disorders
    Bernardini, R.
    Di Benedetto, G.
    Cantarella, G.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S21 - S21
  • [8] The potential of Slit2 as a therapeutic target for central nervous system disorders
    Sherchan, Prativa
    Travis, Zachary D.
    Tang, Jiping
    Zhang, John H.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (08) : 805 - 818
  • [9] Muscarinic Receptors: Their Roles in Disorders of the Central Nervous System and Potential as Therapeutic Targets
    Scarr, Elizabeth
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (05) : 369 - 379
  • [10] A Flavonoid on the Brain: Quercetin as a Potential Therapeutic Agent in Central Nervous System Disorders
    Wrobel-Biedrawa, Dagmara
    Grabowska, Karolina
    Galanty, Agnieszka
    Sobolewska, Danuta
    Podolak, Irma
    LIFE-BASEL, 2022, 12 (04):